These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 15268900)
1. Extracellular calcium downregulates estrogen receptor alpha and increases its transcriptional activity through calcium-sensing receptor in breast cancer cells. Journé F; Dumon JC; Kheddoumi N; Fox J; Laïos I; Leclercq G; Body JJ Bone; 2004 Aug; 35(2):479-88. PubMed ID: 15268900 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
3. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells. Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271 [TBL] [Abstract][Full Text] [Related]
4. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA; Oza BP; Colomer R; Lupu R Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863 [TBL] [Abstract][Full Text] [Related]
5. Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation. Journe F; Laurent G; Chaboteaux C; Nonclercq D; Durbecq V; Larsimont D; Body JJ Breast Cancer Res Treat; 2008 Jan; 107(1):49-61. PubMed ID: 17333335 [TBL] [Abstract][Full Text] [Related]
6. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Kinoshita Y; Chen S Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol. Hung H J Cell Physiol; 2004 Feb; 198(2):197-208. PubMed ID: 14603522 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells. Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315 [TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells. Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952 [TBL] [Abstract][Full Text] [Related]
10. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S; Krishnan AV; Feldman D Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825 [TBL] [Abstract][Full Text] [Related]
11. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Pink JJ; Jordan VC Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of a BMP-6 promoter by estrogen receptor alpha. Ong DB; Colley SM; Norman MR; Kitazawa S; Tobias JH J Bone Miner Res; 2004 Mar; 19(3):447-54. PubMed ID: 15040833 [TBL] [Abstract][Full Text] [Related]
13. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551 [TBL] [Abstract][Full Text] [Related]
14. Anti-estrogenic effects of conjugated linoleic acid through modulation of estrogen receptor phosphorylation. Liu J; Sidell N Breast Cancer Res Treat; 2005 Nov; 94(2):161-9. PubMed ID: 16261415 [TBL] [Abstract][Full Text] [Related]
15. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway. Sengupta K; Banerjee S; Saxena N; Banerjee SK Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315 [TBL] [Abstract][Full Text] [Related]
16. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. Wilson VS; Bobseine K; Gray LE Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400 [TBL] [Abstract][Full Text] [Related]
17. Estrogenic down-regulation of protein tyrosine phosphatase gamma (PTP gamma) in human breast is associated with estrogen receptor alpha. Liu S; Sugimoto Y; Kulp SK; Jiang J; Chang HL; Park KY; Kashida Y; Lin YC Anticancer Res; 2002; 22(6C):3917-23. PubMed ID: 12553013 [TBL] [Abstract][Full Text] [Related]
18. Estrogen responsiveness of IBEP-2, a new human cell line derived from breast carcinoma. Journé F; Body JJ; Leclercq G; Nonclercq D; Laurent G Breast Cancer Res Treat; 2004 Jul; 86(1):39-53. PubMed ID: 15218360 [TBL] [Abstract][Full Text] [Related]
19. Calbindin-D28k and calcium sensing receptor cooperate in MCF-7 human breast cancer cells. Parkash J; Chaudhry MA; Rhoten WB Int J Oncol; 2004 May; 24(5):1111-9. PubMed ID: 15067332 [TBL] [Abstract][Full Text] [Related]
20. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells. Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]